Lexia LLC

FDA Regulatory Profile

Lexia LLC appears in FDA public data with 2 recalls, 0 510(k) clearances, 2 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0829-2026, Class II) was initiated on August 21, 2026.

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
2
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-0829-2026Class IIBroadway Joe's Pain Cream, 3000 gm CBD, (Histamine Dihydrochloride 0.025%) (CDB Isolate 3000mg, HempAugust 21, 2026
D-0828-2026Class IIBroadway Joe's Pain Cream, (Histamine Dihydrochloride 0.025%), 1500mg CBD Isolate, 1000mg Hempseed oAugust 21, 2026